TWD 65.0
(-1.07%)
Year | Gross Profit | Gross Profit Growth |
---|---|---|
2023 | 2.91 Billion TWD | -7.33% |
2022 | 3.14 Billion TWD | -15.63% |
2021 | 3.72 Billion TWD | 1.12% |
2020 | 3.68 Billion TWD | -3.3% |
2019 | 3.8 Billion TWD | 10.85% |
2018 | 3.43 Billion TWD | 26.88% |
2017 | 2.7 Billion TWD | 4.88% |
2016 | 2.58 Billion TWD | -4.6% |
2015 | 2.7 Billion TWD | 1.51% |
2014 | 2.66 Billion TWD | 15.79% |
2013 | 2.3 Billion TWD | 9.86% |
2012 | 2.09 Billion TWD | -3.0% |
2011 | 2.16 Billion TWD | 5.75% |
2010 | 2.04 Billion TWD | -2.28% |
2009 | 2.09 Billion TWD | 357.93% |
2008 | 456.51 Million TWD | 0.0% |
2006 | 1.9 Billion TWD | 7.22% |
2005 | 1.78 Billion TWD | 0.0% |
Year | Gross Profit | Gross Profit Growth |
---|---|---|
2024 Q2 | 872.17 Million TWD | 11.31% |
2024 Q1 | 783.59 Million TWD | -0.41% |
2023 Q4 | 786.85 Million TWD | 5.43% |
2023 FY | 2.91 Billion TWD | -7.33% |
2023 Q1 | 704.03 Million TWD | 12.24% |
2023 Q2 | 724.98 Million TWD | 2.97% |
2023 Q3 | 746.31 Million TWD | 2.94% |
2022 Q3 | 665.18 Million TWD | -28.05% |
2022 FY | 3.14 Billion TWD | -15.63% |
2022 Q1 | 924.42 Million TWD | -4.88% |
2022 Q2 | 924.46 Million TWD | 0.0% |
2022 Q4 | 627.26 Million TWD | -5.7% |
2021 Q2 | 941.53 Million TWD | 10.67% |
2021 Q3 | 959.14 Million TWD | 1.87% |
2021 FY | 3.72 Billion TWD | 1.12% |
2021 Q4 | 971.83 Million TWD | 1.32% |
2021 Q1 | 850.72 Million TWD | -9.75% |
2020 Q2 | 902.16 Million TWD | -1.47% |
2020 Q4 | 942.64 Million TWD | 2.27% |
2020 Q3 | 921.67 Million TWD | 2.16% |
2020 Q1 | 915.63 Million TWD | -9.66% |
2020 FY | 3.68 Billion TWD | -3.3% |
2019 Q2 | 973.21 Million TWD | 16.8% |
2019 Q4 | 1.01 Billion TWD | 2.6% |
2019 FY | 3.8 Billion TWD | 10.85% |
2019 Q1 | 833.23 Million TWD | -8.05% |
2019 Q3 | 987.8 Million TWD | 1.5% |
2018 Q2 | 815.1 Million TWD | 0.32% |
2018 FY | 3.43 Billion TWD | 26.88% |
2018 Q3 | 901.21 Million TWD | 10.56% |
2018 Q1 | 812.49 Million TWD | 11.53% |
2018 Q4 | 906.15 Million TWD | 0.55% |
2017 Q1 | 685.47 Million TWD | 10.21% |
2017 Q2 | 647.77 Million TWD | -5.5% |
2017 Q4 | 728.46 Million TWD | 12.85% |
2017 FY | 2.7 Billion TWD | 4.88% |
2017 Q3 | 645.54 Million TWD | -0.34% |
2016 Q1 | 668.82 Million TWD | -8.52% |
2016 Q4 | 621.94 Million TWD | 0.48% |
2016 Q3 | 618.95 Million TWD | -7.82% |
2016 FY | 2.58 Billion TWD | -4.6% |
2016 Q2 | 671.47 Million TWD | 0.4% |
2015 FY | 2.7 Billion TWD | 1.51% |
2015 Q1 | 633.73 Million TWD | -10.51% |
2015 Q2 | 660.2 Million TWD | 4.18% |
2015 Q3 | 680.56 Million TWD | 3.08% |
2015 Q4 | 731.13 Million TWD | 7.43% |
2014 Q3 | 652.65 Million TWD | -5.72% |
2014 Q2 | 692.25 Million TWD | 13.03% |
2014 FY | 2.66 Billion TWD | 15.79% |
2014 Q4 | 708.12 Million TWD | 8.5% |
2014 Q1 | 612.46 Million TWD | -2.69% |
2013 FY | 2.3 Billion TWD | 9.86% |
2013 Q1 | 547.14 Million TWD | 10.8% |
2013 Q3 | 548.06 Million TWD | -5.1% |
2013 Q2 | 577.49 Million TWD | 5.55% |
2013 Q4 | 629.37 Million TWD | 14.84% |
2012 Q2 | 603.59 Million TWD | 22.42% |
2012 FY | 2.09 Billion TWD | -3.0% |
2012 Q1 | 493.05 Million TWD | -14.61% |
2012 Q4 | 493.79 Million TWD | -1.91% |
2012 Q3 | 503.38 Million TWD | -16.6% |
2011 Q3 | 515.98 Million TWD | 0.0% |
2011 Q2 | - TWD | -100.0% |
2011 Q1 | 506.82 Million TWD | -75.19% |
2011 FY | 2.16 Billion TWD | 5.75% |
2011 Q4 | 577.4 Million TWD | 11.9% |
2010 Q2 | - TWD | 0.0% |
2010 FY | 2.04 Billion TWD | -2.28% |
2010 Q4 | 2.04 Billion TWD | 0.0% |
2010 Q1 | - TWD | 0.0% |
2010 Q3 | - TWD | 0.0% |
2009 FY | 2.09 Billion TWD | 357.93% |
2008 FY | 456.51 Million TWD | 0.0% |
2006 FY | 1.9 Billion TWD | 7.22% |
2005 FY | 1.78 Billion TWD | 0.0% |
Name | Gross Profit | Gross Profit Difference |
---|---|---|
Grape King Bio Ltd | 8.53 Billion TWD | 65.887% |
Standard Chem & Pharm CO., LTD. | 2.72 Billion TWD | -6.813% |
Maywufa Company Ltd. | 854.37 Million TWD | -240.725% |
ScinoPharm Taiwan, Ltd. | 1.21 Billion TWD | -139.399% |
Lotus Pharmaceutical Co., Ltd. | 8.33 Billion TWD | 65.091% |
LIWANLI Innovation Co., Ltd. | 15.08 Million TWD | -19200.278% |
PhytoHealth Corporation | 67.64 Million TWD | -4203.566% |
SCI Pharmtech, Inc. | 350.32 Million TWD | -730.965% |
Formosa Laboratories, Inc. | 1.9 Billion TWD | -52.95% |
PharmaEssentia Corporation | 4.49 Billion TWD | 35.239% |
Bora Pharmaceuticals Co., LTD. | 6.99 Billion TWD | 58.361% |